Urgent Study Launched as Pancreatitis Cases Rise Among Weight Loss Drug Users
London, England — Health officials in the UK have initiated a comprehensive study following numerous reports linking weight loss and diabetes medications to pancreatic issues. Concerns have arisen after hundreds of cases of acute and chronic pancreatitis were associated with glucagon-like peptide-1 (GLP-1) receptor agonists, raising alarms about patient safety. The Medicines and Healthcare products Regulatory Agency (MHRA) has documented significant incidents involving GLP-1 medications since their approval. These reports indicate that among several compounds, …